|
1
|
Kiener HP, Ackermann J, Redlich K, Radda
I, Steiner CW, Bitzan P, Smolen JS and Drach J: Interphase
fluorescence in situ hybridization analysis of fibroblast-like
synoviocytes of patients with rheumatoid arthritis and
osteoarthritis. Arthritis Res Ther. 3(Suppl 2): P1192001.
View Article : Google Scholar
|
|
2
|
Abramson S, Attur M, Dave M, Leung M,
Patel J, Gomez P and Amin A: Paracrine pathways of cartilage
destruction in osteoarthritis. Arthritis Res Ther. 5(Suppl 3):
S22003. View
Article : Google Scholar
|
|
3
|
Sun AR, Panchal SK, Friis T, Sekar S,
Crawford R, Brown L, Xiao Y and Prasadam I: Obesity-associated
metabolic syndrome spontaneously induces infiltration of
pro-inflammatory macrophage in synovium and promotes
osteoarthritis. PLoS One. 12:e01836932017. View Article : Google Scholar
|
|
4
|
Goldring MB and Otero M: Inflammation in
osteoarthritis. Curr Opin Rheumatol. 23:471–478. 2011. View Article : Google Scholar
|
|
5
|
Wojdasiewicz P, Poniatowski LA and
Szukiewicz D: The role of inflammatory and anti-inflammatory
cytokines in the pathogenesis of osteoarthritis. Mediators Inflamm.
2014:5614592014. View Article : Google Scholar
|
|
6
|
Suzuki M, Hashizume M, Yoshida H, Shiina M
and Mihara M: IL-6 and IL-1 synergistically enhanced the production
of MMPs from synovial cells by up-regulating IL-6 production and
IL-1 receptor I expression. Cytokine. 51:178–183. 2010. View Article : Google Scholar
|
|
7
|
Martel-Pelletier J, Boileau C, Pelletier
JP and Roughley PJ: Cartilage in normal and osteoarthritis
conditions. Best Prac Res Clin Rheumatol. 22:351–384. 2008.
View Article : Google Scholar
|
|
8
|
Liu-Bryan R: Synovium and the innate
inflammatory network in osteoarthritis progression. Curr Rheumatol
Rep. 15:3232013. View Article : Google Scholar
|
|
9
|
Ginn SL, Alexander IE, Edelstein ML, Abedi
MR and Wixon J: Gene therapy clinical trials worldwide to 2012 an
update. J Gene Med. 15:65–77. 2013. View
Article : Google Scholar
|
|
10
|
Zhang Y, Wei H, Xu L, Yan G, Ma C, Yu M,
Wei C and Sun Y: Preparation and evaluation of a non-viral gene
vector for SiRNA: Multifunctional envelope-type nano device. Artif
Cells Nanomed Biotechnol. 44:1259–1265. 2016.
|
|
11
|
Yu B, Chen Y, Ouyang C, Huang H, Ji L and
Chao H: A luminescent tetranuclear ruthenium(II) complex as a
tracking non-viral gene vector. Chem Commun (Camb). 49:810–812.
2013. View Article : Google Scholar
|
|
12
|
Malakooty Poor E, Baghaban Eslaminejad M,
Gheibi N, Bagheri F and Atyabi F: Chitosan-pDNA nanoparticle
characteristics determine the transfection efficacy of gene
delivery to human mesenchymal stem cells. Artif Cells Nanomed
Biotechnol. 42:376–384. 2014. View Article : Google Scholar
|
|
13
|
Zhang X, Yu C, Xushi, Zhang C, Tang T and
Dai K: Direct chitosan-mediated gene delivery to the rabbit knee
joints in vitro and in vivo. Biochem Biophys Res Commun.
341:202–208. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Xu X, Qiu S, Zhang Y, Yin J and Min S:
PELA microspheres with encapsulated arginine-chitosan/pBMP-2
nanoparticles induce pBMP-2 controlled-release, transfected
osteoblastic progenitor cells, and promoted osteogenic
differentiation. Artif Cells Nanomed Biotechnol. 45:330–339. 2017.
View Article : Google Scholar
|
|
15
|
Mansouri S, Cuie Y, Winnik F, Shi Q,
Lavigne P, Benderdour M, Beaumont E and Fernandes JC:
Characterization of folate-chitosan-DNA nanoparticles for gene
therapy. Biomaterials. 27:2060–2065. 2006. View Article : Google Scholar
|
|
16
|
Almond A: Hyaluronan. Cell Mol Life Sci.
64:1591–1596. 2007. View Article : Google Scholar
|
|
17
|
Lu HD, Zhao HQ, Wang K and Lv LL: Novel
hyaluronic acid-chitosan nanoparticles as non-viral gene delivery
vectors targeting osteoarthritis. Int J Pharm. 420:358–365. 2011.
View Article : Google Scholar
|
|
18
|
Lu H, Lv L, Dai Y, Wu G, Zhao H and Zhang
F: Porous chitosan scaffolds with embedded hyaluronic
acid/chitosan/plasmid-DNA nanoparticles encoding TGF-β1 induce DNA
controlled release, transfected chondrocytes, and promoted cell
proliferation. PLoS One. 8:e699502013. View Article : Google Scholar
|
|
19
|
Qiu B, Gong M, He QT and Zhou PH:
Controlled release of interleukin-1 receptor antagonist from
hyaluronic acid-chitosan microspheres attenuates interleukin-1
β-induced inflammation and apoptosis in chondrocytes. Biomed Res
Int. 2016:62909572016. View Article : Google Scholar
|
|
20
|
Ma BL, Zhou PH, Xie T, Shi L, Qiu B and
Wang Q: Inhibition of interleukin-1beta-stimulated
dedifferentiation of chondrocytes via controlled release of CrmA
from hyaluronic acid-chitosan microspheres. BMC Musculoskelet
Disord. 16:612015. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Dobo J, Swanson R, Salvesen GS, Olson ST
and Gettins PG: Cytokine response modifier a inhibition of
initiator caspases results in covalent complex formation and
dissociation of the caspase tetramer. J Biol Chem. 281:38781–38790.
2006. View Article : Google Scholar
|
|
22
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(−Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar
|
|
23
|
Zhou PH, Qiu B, Deng RH, Li HJ, Xu XF and
Shang XF: Chondroprotective effects of hyaluronic acid-chitosan
nanoparticles containing plasmid DNA encoding cytokine response
modifier a in a rat knee osteoarthritis model. Cell Physiol
Biochem. 47:1207–1216. 2018. View Article : Google Scholar
|
|
24
|
Luangtana-Anan M, Limmatvapirat S,
Nunthanid J, Chalongsuk R and Yamamoto K: Polyethylene glycol on
stability of chitosan microparticulate carrier for protein. AAPS
Pharmscitech. 11:1376–1382. 2010. View Article : Google Scholar
|
|
25
|
Hou Y, Hu J, Park H and Lee M:
Chitosan-based nanoparticles as a sustained protein release carrier
for tissue engineering applications. J Biomed Mater Res A.
100:939–947. 2012. View Article : Google Scholar :
|
|
26
|
Kang YM, Lee BN, Ko JH, Kim GH, Kang KN,
Kim DY, Kim JH, Park YH, Chun HJ, Kim CH and Kim MS: In vivo
biocompatibility study of electrospun chitosan microfiber for
tissue engineering. Int J Mol Sci. 11:4140–4148. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Wang L and Stegemann JP: Thermogelling
chitosan and collagen composite hydrogels initiated with
beta-glycerophosphate for bone tissue engineering. Biomaterials.
31:3976–3985. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Masarudin MJ, Cutts SM, Pietersz GA,
Evison BJ, Phillips DR and Pigram PJ: Factors determining the
stability, size distribution, and cellular accumulation of small,
monodisperse chitosan nanoparticles as candidate vectors for
anticancer drug delivery: Application to the passive encapsulation
of [(14) C]-doxorubicin. Nanotechnol Sci Appl. 9:47. 2016.
View Article : Google Scholar
|
|
29
|
Huang D, Wang R and Yang S: Cogels of
hyaluronic acid and acellular matrix for cultivation of
adipose-derived stem cells: Potential application for vocal fold
tissue engineering. Biomed Res Int. 2016:65840542016. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Shi J, Ma R, Wang L, Zhang J, Liu R, Li L,
Liu Y, Hou L, Yu X, Gao J and Zhang Z: The application of
hyaluronic acid-derivatized carbon nanotubes in hematoporphyrin
monomethyl ether-based photodynamic therapy for in vivo and in
vitro cancer treatment. Int J Nanomedicine. 8:2361–2373. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Huberlant S, Fernandez H, Vieille P,
Khrouf M, Ulrich D, deTayrac R and Letouzey V: Application of a
hyaluronic acid gel after intrauterine surgery may improve
spontaneous fertility: A randomized controlled trial in new zealand
white rabbits. Plos One. 10:e01256102015. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Kim Y and Kumar S: CD44-mediated adhesion
to hyaluronic acid contributes to mechanosensing and invasive
motility. Mol Cancer Res. 12:1416–1429. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Contreras-Ruiz L, de la Fuente M, Parraga
JE, López-García A, Fernández I, Seijo B, Sánchez A, Calonge M and
Diebold Y: Intracellular trafficking of hyaluronic acid-chitosan
oligomer-based nanoparticles in cultured human ocular surface
cells. Mol Vis. 17:279–290. 2011.
|
|
34
|
Centelles MN, Qian C, Campanero MA and
Irache JM: New methodologies to characterize the effectiveness of
the gene transfer mediated by DNA-chitosan nanoparticles. Int J
Nanomedicine. 3:451–460. 2008.
|
|
35
|
Chen Y, Mohanraj VJ, Wang F and Benson HA:
Designing chitosan-dextran sulfate nanoparticles using charge
ratios. AAPS Pharmscitech. 8:E982007. View Article : Google Scholar
|
|
36
|
Oliverira AV, Silva AP, Bitoque DB, Silva
GA and Rosa da Costa AM: Transfection efficiency of chitosan and
thiolated chitosan in retinal pigment epithelium cells: A
comparative study. J Pharm Bioallied Sci. 5:111–118. 2013.
View Article : Google Scholar
|
|
37
|
Granot E, Shouval D and Ashur Y: Cell
adhesion molecules and hyaluronic acid as markers of inflammation,
fibrosis and response to antiviral therapy in chronic hepatitis C
patients. Mediators Inflamm. 10:253–258. 2001. View Article : Google Scholar
|
|
38
|
Khurana SS, Riehl TE, Moore BD, Fassan M,
Rugge M, Romero-Gallo J, Noto J, Peek RM Jr, Stenson WF and Mills
JC: The hyaluronic acid receptor CD44 coordinates normal and
metaplastic gastric epithelial progenitor cell proliferation. J
Biol Chem. 288:16085–16097. 2013. View Article : Google Scholar
|
|
39
|
Wang T, Hou J, Su C, Zhao L and Shi Y:
Hyaluronic acid-coated chitosan nanoparticles induce ROS-mediated
tumor cell apoptosis and enhance antitumor efficiency by targeted
drug delivery via CD44. J Nanobiotechnology. 15:72017. View Article : Google Scholar :
|
|
40
|
Aborehab NM, El Bishbishy MH, Refaiy A and
Waly NE: A putative Chondroprotective role for IL-1 beta and MPO in
herbal treatment of experimental osteoarthritis. BMC Complement
Altern Med. 17:4952017. View Article : Google Scholar
|
|
41
|
Afif H, Benderdour M, Mfuna-Endam L,
Martel-Pelletier J, Pelletier JP, Duval N and Fahmi H: Peroxisome
proliferator-activated receptor gamma 1 expression is diminished in
human osteoarthritis cartilage and is downregulated by IL-1 beta in
articular chondrocytes. Arthritis Res Ther. 9:R312007. View Article : Google Scholar
|
|
42
|
Chia WT, Yeh LT, Chen YW, Lee HS, Chang DM
and Sytwu HK: IL-1 beta in irrigation fluid and mRNA expression in
synovial tissue of the knee joint as therapeutic markers of
inflammation in collagen antibody-induced arthritis. Dis Markers.
26:1–7. 2009. View Article : Google Scholar
|
|
43
|
Ekert PG, Silke J and Vaux DL: Inhibition
of apoptosis and clonogenic survival of cells expressing crmA
variants: Optimal caspase substrates are not necessarily optimal
inhibitors. EMBO J. 18:330–338. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Mayer-Barber KD, Barber DL, Shenderov K,
White SD, Wilson MS, Cheever A, Kugler D, Hieny S, Caspar P, Núñez
G, et al: Cutting edge: Caspase-1 independent IL-1 beta production
is critical for host resistance to mycobacterium tuberculosis and
does not require TLR signaling in vivo. J Immunol. 184:3326–3330.
2010. View Article : Google Scholar
|
|
45
|
Wang F and He X: Intra-articular
hyaluronic acid and corticosteroids in the treatment of knee
osteoarthritis: A meta-analysis. Exp Ther Med. 9:493–500. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Georgopoulou A, Kaliva M, Vamvakaki M and
Chatzinikolaidou M: Osteogenic potential of pre-osteoblastic cells
on a chitosan-graft-polycaprolactone copolymer. Materials (Basel).
11:E4902018. View Article : Google Scholar
|
